We see Novo Nordisk and Eli Lilly as overvalued despite assuming that a quarter of US adults with obesity will be on GLP-1 therapies by 2031, leading to a GLP-1 market north of $200 billion in 2031, before generic semaglutide (Wegovy/Ozempic/Rybelsus) launches. Competition rises
It helps by improving how the body uses insulin, lowering blood glucose, and supporting weight reduction
Eligible panellists required a minimum of 5 years post-speciality clinical practice experience managing CKD and/or T2D and were based across 10 countries (Supplementary Material Table S2)
It is ideal for addressing hyperpigmentation, oxidative stress, and signs of aging
The breadth of these effects is the point: the receptor does not appear to act through a single disease-specific mechanism but through a general increase in neuronal resilience
Enzymatic reduction of disulf ide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT) Proc Natl Acad Sci U S A
